• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国与美国甲状腺影像报告与数据系统在评估不确定甲状腺结节恶性风险中的比较。

Comparison of Korean vs. American Thyroid Imaging Reporting and Data System in Malignancy Risk Assessment of Indeterminate Thyroid Nodules.

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

出版信息

Endocrinol Metab (Seoul). 2021 Oct;36(5):1111-1120. doi: 10.3803/EnM.2021.1208. Epub 2021 Oct 21.

DOI:10.3803/EnM.2021.1208
PMID:34674501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8566128/
Abstract

BACKGROUND

The management of cytologically indeterminate thyroid nodules is challenging for clinicians. This study aimed to compare the diagnostic performance of the Korean Thyroid Imaging Reporting and Data Systems (K-TIRADS) with that of the American College of Radiology (ACR)-TIRADS for predicting the malignancy risk of indeterminate thyroid nodules.

METHODS

Thyroid nodules diagnosed by fine-needle aspiration (FNA) followed by surgery or core needle biopsy at a single referral hospital were enrolled.

RESULTS

Among 200 thyroid nodules, 78 (39.0%) nodules were classified as indeterminate by FNA (Bethesda category III, IV, and V), and 114 (57.0%) nodules were finally diagnosed as malignancy by surgery or core needle biopsy. The area under the curve (AUC) was higher for FNA than for either TIRADS system in all nodules, while all three methods showed similar AUCs for indeterminate nodules. However, for Bethesda category III nodules, applying K-TIRADS 5 significantly increased the risk of malignancy compared to a cytological examination alone (50.0% vs. 26.5%, P=0.028), whereas applying ACR-TIRADS did not lead to a change.

CONCLUSION

K-TIRADS and ACR-TIRADS showed similar diagnostic performance in assessing indeterminate thyroid nodules, and K-TIRADS had beneficial effects for malignancy prediction in Bethesda category III nodules.

摘要

背景

细胞学不确定的甲状腺结节的管理对临床医生来说具有挑战性。本研究旨在比较韩国甲状腺影像报告和数据系统(K-TIRADS)与美国放射学院(ACR)-TIRADS 对预测不确定甲状腺结节恶性风险的诊断性能。

方法

在一家转诊医院,通过细针抽吸(FNA)诊断的甲状腺结节随后进行手术或核心针活检。

结果

在 200 个甲状腺结节中,78 个(39.0%)结节通过 FNA 被归类为不确定(Bethesda 类别 III、IV 和 V),114 个(57.0%)结节最终通过手术或核心针活检被诊断为恶性。在所有结节中,FNA 的曲线下面积(AUC)均高于两种 TIRADS 系统,而所有三种方法对不确定结节的 AUC 均相似。然而,对于 Bethesda 类别 III 结节,与单独细胞学检查相比,应用 K-TIRADS 5 显著增加了恶性风险(50.0%比 26.5%,P=0.028),而应用 ACR-TIRADS 则没有改变。

结论

K-TIRADS 和 ACR-TIRADS 在评估不确定甲状腺结节方面表现出相似的诊断性能,并且 K-TIRADS 对 Bethesda 类别 III 结节的恶性预测具有有益影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8a/8566128/9123518ad083/enm-2021-1208f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8a/8566128/9123518ad083/enm-2021-1208f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8a/8566128/9123518ad083/enm-2021-1208f1.jpg

相似文献

1
Comparison of Korean vs. American Thyroid Imaging Reporting and Data System in Malignancy Risk Assessment of Indeterminate Thyroid Nodules.韩国与美国甲状腺影像报告与数据系统在评估不确定甲状腺结节恶性风险中的比较。
Endocrinol Metab (Seoul). 2021 Oct;36(5):1111-1120. doi: 10.3803/EnM.2021.1208. Epub 2021 Oct 21.
2
Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?美国甲状腺协会、K-TIRADS 和 ACR-TIRADS 超声分类系统能否用于预测 Bethesda Ⅳ类结节中的恶性肿瘤?
Endocr Pract. 2020 Sep;26(9):945-952. doi: 10.4158/EP-2020-0024.
3
Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.基于细针抽吸细胞学和韩国甲状腺影像报告和数据系统的细胞学-超声风险分层评分系统。
Thyroid. 2017 Jul;27(7):953-959. doi: 10.1089/thy.2016.0603. Epub 2017 May 19.
4
Diagnostic performance of ACR-TIRADS, Korean TIRADS, and American Thyroid Association guidelines for risk stratification of thyroid nodules: a prospective study.ACR-TIRADS、韩国 TIRADS 和美国甲状腺协会甲状腺结节风险分层指南的诊断性能:一项前瞻性研究。
J Ultrasound. 2022 Dec;25(4):887-894. doi: 10.1007/s40477-022-00669-0. Epub 2022 Mar 7.
5
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
6
American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.美国放射学院甲状腺影像报告和数据系统联合 K-RAS 突变可改善细胞学不确定的甲状腺结节的管理。
PLoS One. 2019 Jul 11;14(7):e0219383. doi: 10.1371/journal.pone.0219383. eCollection 2019.
7
Approach to Bethesda system category III thyroid nodules according to US-risk stratification.根据美国风险分层,贝塞斯达系统类别 III 甲状腺结节的处理方法。
Endocr J. 2022 Jan 28;69(1):67-74. doi: 10.1507/endocrj.EJ21-0300. Epub 2021 Aug 18.
8
[Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF Mutation in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance].[美国甲状腺协会指南、美国放射学会甲状腺影像报告和数据系统以及中国甲状腺影像报告和数据系统单独及联合BRAF突变在意义不明确的非典型性病变/意义不明确的滤泡性病变中的诊断价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Dec 30;45(6):921-928. doi: 10.3881/j.issn.1000-503X.15754.
9
Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.超声 K-TIRADS 分类与 2015 年 ATA 指南在甲状腺结节及滤泡性肿瘤良恶性危险分层中的诊断效能
AJR Am J Roentgenol. 2019 Aug;213(2):444-450. doi: 10.2214/AJR.18.20961. Epub 2019 Apr 30.
10
Correlation of TIRADS scoring in thyroid nodules with preoperative fine needle aspiration biopsy and postoperative specimen pathology.甲状腺结节 TIRADS 评分与术前细针穿刺活检及术后标本病理的相关性。
Head Neck. 2024 Apr;46(4):849-856. doi: 10.1002/hed.27622. Epub 2024 Jan 10.

引用本文的文献

1
Diagnostic efficiency among Eu-/C-/ACR-TIRADS and S-Detect for thyroid nodules: a systematic review and network meta-analysis.超声弹性成像技术在甲状腺结节诊断中的应用价值:一项系统评价和网状 Meta 分析。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1227339. doi: 10.3389/fendo.2023.1227339. eCollection 2023.
2
Current controversies in the management of patients with indeterminate thyroid nodules.目前对甲状腺结节患者管理的争议。
Saudi Med J. 2023 Jul;44(7):633-639. doi: 10.15537/smj.2023.44.7.2023-0049.
3
The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules.

本文引用的文献

1
Atypia of undetermined significance/follicular lesion of undetermined significance: Asian non-Asian practice, and the Singapore experience.意义不明确的非典型性/意义不明确的滤泡性病变:亚洲与非亚洲的实践及新加坡经验
Gland Surg. 2020 Oct;9(5):1764-1787. doi: 10.21037/gs-20-555.
2
Diagnostic Value of Six Thyroid Imaging Reporting and Data Systems (TIRADS) in Cytologically Equivocal Thyroid Nodules.六种甲状腺影像报告和数据系统(TIRADS)对甲状腺细针穿刺结果不明确结节的诊断价值
J Clin Med. 2020 Jul 17;9(7):2281. doi: 10.3390/jcm9072281.
3
Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype.
甲状腺影像报告和数据系统对贝塞斯达Ⅲ级甲状腺结节管理的影响。
J Taibah Univ Med Sci. 2022 Nov 14;18(3):506-511. doi: 10.1016/j.jtumed.2022.10.009. eCollection 2023 Jun.
4
Diagnostic Performance of Various Ultrasound Risk Stratification Systems for Benign and Malignant Thyroid Nodules: A Meta-Analysis.各种超声风险分层系统对甲状腺良恶性结节的诊断性能:一项荟萃分析。
Cancers (Basel). 2023 Jan 9;15(2):424. doi: 10.3390/cancers15020424.
5
Diagnostic Performance of ACR and Kwak TI-RADS for Benign and Malignant Thyroid Nodules: An Update Systematic Review and Meta-Analysis.美国放射学会(ACR)和夸克甲状腺影像报告和数据系统(Kwak TI-RADS)对甲状腺良恶性结节的诊断效能:一项更新的系统评价和荟萃分析
Cancers (Basel). 2022 Dec 2;14(23):5961. doi: 10.3390/cancers14235961.
6
Comparison of Thyroid Imaging Reporting and Data Systems in Malignancy Risk Stratification of Indeterminate Thyroid Nodules.甲状腺影像报告和数据系统在甲状腺结节恶性风险分层中的比较
Endocrinol Metab (Seoul). 2021 Oct;36(5):974-976. doi: 10.3803/EnM.2021.1287. Epub 2021 Oct 28.
根据超声风险分层系统和细胞亚型划分的贝塞斯达Ⅲ类甲状腺结节的恶性率
Medicine (Baltimore). 2020 Jan;99(2):e18780. doi: 10.1097/MD.0000000000018780.
4
Validation and comparison of three newly-released Thyroid Imaging Reporting and Data Systems for cancer risk determination.三种新发布的甲状腺影像报告和数据系统用于癌症风险评估的验证和比较。
Endocrine. 2019 May;64(2):299-307. doi: 10.1007/s12020-018-1817-8. Epub 2018 Nov 24.
5
Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS.在提高诊断准确性的同时减少不必要的甲状腺活检:走向“正确”的 TIRADS。
J Clin Endocrinol Metab. 2019 Jan 1;104(1):95-102. doi: 10.1210/jc.2018-01674.
6
Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.根据核和结构异型性对 Bethesda 不典型和滤泡性肿瘤类别的细分可提高甲状腺恶性风险的鉴别能力。
Thyroid. 2018 Apr;28(4):511-521. doi: 10.1089/thy.2017.0274. Epub 2018 Mar 29.
7
American Thyroid Association ultrasound system for the initial assessment of thyroid nodules: Use in stratifying the risk of malignancy of indeterminate lesions.美国甲状腺协会用于甲状腺结节初始评估的超声系统:用于对不确定病变的恶性风险进行分层。
Head Neck. 2018 Apr;40(4):722-727. doi: 10.1002/hed.25038. Epub 2017 Dec 16.
8
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.欧洲甲状腺协会成人甲状腺结节超声恶性风险分层指南:欧盟甲状腺影像报告和数据系统(EU-TIRADS)
Eur Thyroid J. 2017 Sep;6(5):225-237. doi: 10.1159/000478927. Epub 2017 Aug 8.
9
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
10
Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.使用2015年美国甲状腺协会(ATA)指南定义的超声模式对具有意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS)细胞学特征的甲状腺结节进行风险分层。
Ann Otol Rhinol Laryngol. 2017 Sep;126(9):625-633. doi: 10.1177/0003489417719472. Epub 2017 Jul 18.